Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry McFarland

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Neuroimmunology|February 9, 2011
The importance of clinical trials in unraveling the mysteries of multiple sclerosisHenry McFarland
Annals of Neurology|January 26, 2012
Comment on "Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation"Bibiana Bielekova, Henry McFarland
Journal of Neuroimmunology|February 20, 2017
Introduction to the Special IssueHenry McFarland, Daniel S Reich, Steven Jacobson
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosisBibiana Bielekova, Myong-Hee Sung, Nadja Kadom, et al.
Neurology|January 11, 2013
CNS vasculitis in a patient with MS on daclizumab monotherapyJoan Ohayon, Unsong Oh, Nancy Richert, et al.
Brain : a Journal of Neurology|October 23, 2003
Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI studyJens Wuerfel, Judith Bellmann-Strobl, Peter Brunecker, et al.
Archives of Neurology|April 15, 2009
Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosisUnsong Oh, Gregg Blevins, Caitlin Griffith, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 22, 2015
Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple SclerosisLael Anne Stone, Gary Raymond Cutter, Elizabeth Fisher, et al.
Expert Opinion on Biological Therapy|November 8, 2008
The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosisDeeya Gaindh, Neal Jeffries, Joan Ohayon, et al.
Annals of Neurology|May 4, 2004
Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosisStasia A Anderson, Jacqueline Shukaliak-Quandt, Elaine K Jordan, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Neuroimmunology|February 9, 2011
The importance of clinical trials in unraveling the mysteries of multiple sclerosisHenry McFarland
Annals of Neurology|January 26, 2012
Comment on "Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation"Bibiana Bielekova, Henry McFarland
Journal of Neuroimmunology|February 20, 2017
Introduction to the Special IssueHenry McFarland, Daniel S Reich, Steven Jacobson
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2004
Expansion and functional relevance of high-avidity myelin-specific CD4+ T cells in multiple sclerosisBibiana Bielekova, Myong-Hee Sung, Nadja Kadom, et al.
Neurology|January 11, 2013
CNS vasculitis in a patient with MS on daclizumab monotherapyJoan Ohayon, Unsong Oh, Nancy Richert, et al.
Brain : a Journal of Neurology|October 23, 2003
Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI studyJens Wuerfel, Judith Bellmann-Strobl, Peter Brunecker, et al.
Archives of Neurology|April 15, 2009
Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosisUnsong Oh, Gregg Blevins, Caitlin Griffith, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 22, 2015
Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple SclerosisLael Anne Stone, Gary Raymond Cutter, Elizabeth Fisher, et al.
Expert Opinion on Biological Therapy|November 8, 2008
The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosisDeeya Gaindh, Neal Jeffries, Joan Ohayon, et al.
Annals of Neurology|May 4, 2004
Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosisStasia A Anderson, Jacqueline Shukaliak-Quandt, Elaine K Jordan, et al.
Pageof 2